Dose-response Study of Exendin-9,39 on Glucose Metabolism

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Adrian Vella, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01218633
First received: October 8, 2010
Last updated: January 18, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
No publications provided by Mayo Clinic

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):